# Protege Extension Trial - Long Term Follow Up Trial for Subjects Who Completed the Protege Study (CP-MGA031-01)

> **NCT00870818** · NA · TERMINATED · sponsor: **MacroGenics** · enrollment: 219 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DIAGNOSTIC_TEST:** Blood samples for safety
- **BEHAVIORAL:** Patient reported outcome questionnaires
- **DIAGNOSTIC_TEST:** Analysis of T-cell subsets

## Key facts

- **NCT ID:** NCT00870818
- **Lead sponsor:** MacroGenics
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-02
- **Primary completion:** 2011-02
- **Final completion:** 2011-05
- **Target enrollment:** 219 (ACTUAL)
- **Why stopped:** Business decision
- **Last updated:** 2023-08-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00870818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00870818, "Protege Extension Trial - Long Term Follow Up Trial for Subjects Who Completed the Protege Study (CP-MGA031-01)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00870818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*